44	How much impact do masks have on preventing the spread of the COVID-19? masks, COVID-19, impact, spread prevention, mask effectiveness, respiratory protection, virus transmission, public health, mask types, face coverings, protective equipment, epidemiology mask, COVID-19, prevention, impact, effectiveness, transmission, respiratory droplets, face covering, mask efficacy, virus spread, public health, protective gear, social distancing, respiratory protection masks, COVID-19, impact, prevention, virus spread, efficacy, face coverings, transmission, respiratory viruses, public health masks, COVID-19, prevention, spread, impact, effectiveness, transmission, face coverings, respiratory droplets, asymptomatic, viral transmission, public health, mask efficacy masks, COVID-19, impact, effectiveness, transmission, prevention, mask efficacy, viral spread, airborne, filtration, respiratory protection, public health, pandemic control
45	How has the COVID-19 pandemic impacted mental health? COVID-19, pandemic, mental health, psychological impact, depression, anxiety, stress, quarantine, social isolation, healthcare, mental health services, telehealth, emotional well-being, public health, coping strategies, resilience, mental health statistics COVID-19, pandemic, mental health, psychological impact, anxiety, depression, stress, quarantine, social isolation, healthcare, telemedicine, coping, resilience, mental health services COVID-19, pandemic, mental health, psychological impact, anxiety, depression, stress, isolation, quarantine, healthcare, telemedicine, mental health services, grief, trauma, coping strategies, mental health statistics, public health, social distancing, economic impact COVID-19, pandemic, mental health, impact, psychological effects, anxiety, depression, stress, quarantine, social distancing, mental health services, telemedicine, resilience, coping strategies, loneliness, emotional well-being COVID-19, pandemic, mental health, impact, psychological effects, anxiety, depression, stress, quarantine, social isolation, healthcare, telehealth, coping mechanisms, resilience, mental health services
46	what evidence is there for dexamethasone as a treatment for COVID-19? dexamethasone, COVID-19, treatment, evidence, clinical trials, effectiveness, corticosteroids, randomized controlled trials, RECOVERY trial, cytokine storm, mortality, study results, antiviral therapy, immune response dexamethasone, COVID-19, treatment, evidence, clinical trials, efficacy, corticosteroids, randomized controlled trials, RECOVERY trial, outcomes, respiratory support dexamethasone, COVID-19, treatment, evidence, clinical trials, efficacy, corticosteroids, RECOVERY trial, outcomes, mortality, randomized controlled trial, antiviral, immune response dexamethasone, COVID-19, treatment, evidence, clinical trials, efficacy, randomized controlled trials, RECOVERY trial, corticosteroids, patient outcomes, mortality reduction dexamethasone, COVID-19, treatment, evidence, clinical trials, efficacy, corticosteroid, research, outcomes, guidelines
47	what are the health outcomes for children who contract COVID-19? children, COVID-19, health outcomes, pediatric, illness, symptoms, complications, long-term effects, recovery, vaccination, immunity, severity, hospitalization, mental health, developmental impact children, COVID-19, health outcomes, pediatric, infection, symptoms, long-term effects, hospitalization, vaccination, immunity children, COVID-19, health outcomes, pediatric, infection, complications, long-term effects, recovery, symptoms, immunity, vaccines, hospitalization, clinical studies, pediatric health COVID-19, children, health outcomes, pediatric, infection, symptoms, long-term effects, recovery, complications, immunity COVID-19, children, health outcomes, pediatric, infection, long-term effects, symptoms, respiratory, mental health, neurological, hospitalization, recovery, vaccine, immunity, epidemiology
48	what are the benefits and risks of re-opening schools in the midst of the COVID-19 pandemic? benefits,risks,reopening,s chools,covid-19,pandemic,child health,student safety,learning disruption,mental health,transmission,public health,educational outcomes,community spread,preventive measures,health protocols,vaccination,remote learning,school closure,epidemiology,health equity COVID-19, schools, reopening, benefits, risks, pandemic, education, health, safety, transmission, mental health, academic performance, remote learning, vaccination, public health, social development, infection control, policy, student safety, teacher safety COVID-19, schools, reopening, benefits, risks, pandemic, education, health, safety, transmission, mitigation, vaccination, mental health, academic performance, policies, guidelines, social distancing, remote learning, infection control, community spread school reopening, COVID-19, pandemic, benefits, risks, children, transmission, safety measures, remote learning, in-person education, health protocols, mental health, academic progress, infection control, public health, vaccination, variants, community spread, policy, risk assessment re-opening, schools, COVID-19, pandemic, benefits, risks, safety, transmission, children, health, education, public health, mitigation, policies, vaccination, mental health, learning, infection control, community impact
49	do individuals who recover from COVID-19 show sufficient immune response, including antibody levels and T-cell mediated immunity, to prevent re-infection? COVID-19, immune response, antibody levels, T-cell immunity, re-infection, recovery, immunity, reinfection prevention, immune system, SARS-CoV-2, immune durability, immune memory COVID-19, immune response, antibody levels, T-cell immunity, re-infection, recovery, immune system, SARS-CoV-2, immunity duration, reinfection risk, immune memory, cellular immunity COVID-19, immune response, antibody levels, T-cell immunity, re-infection, recovery, immunity, reinfection prevention, immune memory, SARS-CoV-2, immune system, adaptive immunity, humoral immunity, cellular immunity COVID-19, immune response, antibody levels, T-cell immunity, re-infection, recovery, immunity duration, immune memory, SARS-CoV-2, reinfection risk COVID-19, immune response, recovery, reinfection, antibody levels, T-cell immunity, immune protection, immune memory, SARS-CoV-2, immune defense, immunity duration, immune system, re-infection prevention
50	what is known about an mRNA vaccine for the SARS-CoV-2 virus? mRNA vaccine, SARS-CoV-2, COVID-19, coronavirus, vaccine development, immunology, vaccine efficacy, clinical trials, mRNA technology, Spike protein, immune response, vaccine safety, Moderna, Pfizer-BioNTech, vaccination, viral mutation, mRNA delivery, antibody production, vaccine mechanism, public health mRNA vaccine, SARS-CoV-2, COVID-19, mRNA technology, vaccine efficacy, vaccine safety, vaccine development, immunization, coronavirus, pandemic response, COVID-19 immunity, vaccine mechanism, clinical trials, spike protein, vaccine side effects mRNA vaccine, SARS-CoV-2, COVID-19, vaccine mechanism, mRNA technology, vaccine efficacy, vaccine safety, immunization, virus structure, spike protein, immune response, clinical trials, mRNA delivery, lipid nanoparticles, vaccine development, public health, pandemic response mRNA vaccine,SARS-CoV-2,COVID-19,vaccine mechanism,immune response,clinical trials,efficacy,safety,development,technology,RNA-based,immunization,public health,virus mutation,booster doses mRNA vaccine, SARS-CoV-2, COVID-19, vaccine technology, vaccine efficacy, vaccine safety, Pfizer, Moderna, immune response, viral vector, mRNA technology, antibody production, clinical trials, vaccine development, pandemic, vaccination, immunization, COVID-19 variants, vaccine controversy
10	has social distancing had an impact on slowing the spread of COVID-19? social distancing, COVID-19, impact, disease transmission, infectious disease control, pandemic response, public health measures, virus spread, social behavior, epidemiology social distancing, COVID-19, impact, spread, transmission, effectiveness, measures, pandemic, public health, infection rate social distancing, COVID-19, pandemic, virus transmission, public health measures, infection rate, disease spread, social behavior, epidemiology, containment strategies social distancing, COVID-19, impact, virus spread, pandemic, public health, infection control, transmission, mitigation strategies, social behavior social distancing, COVID-19, virus transmission, pandemic mitigation, infectious disease control, public health measures, social behavior, disease spread, epidemiology, virus containment
11	what are the guidelines for triaging patients infected with coronavirus? COVID-19, triage, guidelines, protocols, infection, pandemic, respiratory symptoms, prioritization, assessment, patient management, clinical criteria, infectious disease, healthcare protocols triage, guidelines, coronavirus, COVID-19, patients, infection, protocols, assessment, prioritization, healthcare, emergency, screening, criteria COVID-19, triage, guidelines, patient assessment, infection control, respiratory symptoms, vital signs, risk stratification, emergency protocols, isolation, healthcare protocols, symptom severity, diagnostic criteria, treatment prioritization COVID-19, triage, guidelines, patient assessment, infection control, clinical criteria, prioritization, severity, hospital protocols, screening, respiratory symptoms, resource allocation, emergency response, isolation procedures triaging, coronavirus, guidelines, COVID-19, patient assessment, infection control, healthcare protocols, emergency triage, clinical criteria, symptomatic management
12	what are best practices in hospitals and at home in maintaining quarantine? quarantine, hospitals, home, best practices, infection control, isolation, hygiene, personal protective equipment, PPE, patient management, sanitation, social distancing, contact tracing, telemedicine, environmental cleaning quarantine, hospitals, home, best practices, infection control, isolation, hygiene, social distancing, PPE, sanitization, patient care, public health, safety protocols quarantine, hospitals, home, best practices, infection control, isolation, safety protocols, health measures, pandemic, pathogen transmission, hygiene, social distancing, personal protective equipment, patient isolation, disinfection, staff training, home quarantine tips quarantine, hospitals, home, best practices, infection control, isolation, hygiene, social distancing, personal protective equipment, disinfecting, patient management, remote monitoring, health protocols, COVID-19, disease prevention quarantine, hospitals, home, best practices, infection control, hygiene, isolation, patient safety, PPE, contact tracing, sanitation, social distancing, hygiene protocols, health guidelines
13	what are the transmission routes of coronavirus? coronavirus, transmission, routes, COVID-19, spread, infection, airborne, droplets, contact, fomites, respiratory, virus, contagion coronavirus, transmission, routes, infection, spread, COVID-19, airborne, droplet, contact, fomite, respiratory, incubation, asymptomatic, person-to-person coronavirus, transmission, routes, spread, infection, modes, pathways, respiratory, contact, droplets, aerosols, fomites, incubation, person-to-person, contamination coronavirus, transmission, routes, COVID-19, spread, infection, airborne, droplets, contact, fomites, aerosols, incubation, person-to-person coronavirus, transmission, routes, spread, infection, COVID-19, airborne, droplets, contact, fomites, hygiene, respiratory, asymptomatic, incubation, virus, contamination
14	what evidence is there related to COVID-19 super spreaders COVID-19, super spreaders, transmission, evidence, outbreaks, epidemiology, viral load, superspreading events, contagion, infectiousness, transmission dynamics, risk factors, case studies COVID-19, super spreaders, transmission, evidence, outbreaks, viral load, aerosols, superspreading events, epidemiology, infectiousness, contact tracing, asymptomatic spread, case studies, public health, intervention strategies COVID-19, super spreaders, transmission, viral load, asymptomatic carriers, superspreading events, viral shedding, contact tracing, epidemiology, infectiousness, outbreak clusters, viral variants, public health measures COVID-19, super spreaders, transmission, viral load, infectivity, epidemiology, superspreading events, aerosol transmission, contact tracing, outbreak investigation, viral shedding, infectiousness, superspreader characteristics, case studies, transmission dynamics COVID-19, super spreaders, transmission, evidence, outbreak, viral load, superspreading events, epidemiology, infection risk, hotspots, asymptomatic carriers, social behavior, infectiousness, viral shedding, contact tracing
15	how long can the coronavirus live outside the body coronavirus, lifespan, outside the body, surface stability, virus survival, environmental stability, persistence, transmission, fomites, contamination, duration, temperature, humidity, disinfectants, viability, surface testing COVID-19, coronavirus, viability, survival time, surface stability, fomites, virus persistence, transmission, environmental stability, surface survival coronavirus, COVID-19, virus survival, environmental stability, surface lifespan, viable virus, contamination, fecal-oral transmission, transmission risk, virus persistence, inanimate surfaces, environmental conditions, duration outside body, virus decay, pandemic, infection control coronavirus, COVID-19, virus survival, surface stability, lifespan outside body, surface contamination, virus persistence, environmental stability, virus longevity, fomite transmission coronavirus, COVID-19, survive, outside, surface, environmental stability, lifespan, persistence, duration, fomites, contamination, disinfection, stability, surface viability
16	how long does coronavirus remain stable  on surfaces? coronavirus, stability, surface, longevity, persistence, survival, decontamination, fomite, environmental stability, transmission, surface type, temperature, humidity, disinfectants coronavirus, stability, surface, duration, survival, persistence, longevity, fomites, contamination, transmission coronavirus, stability, surfaces, duration, survival, persistence, contamination, transfer, fomites, duration of viability coronavirus, stability, surface, duration, persistence, lifespan, viability, contamination, fomite, transmission coronavirus, stability, surface, duration, longevity, persistence, fomite, transmission, virus, survival
17	are there any clinical trials available for the coronavirus clinical trials, coronavirus, COVID-19, SARS-CoV-2, clinical study, research, vaccine trials, treatment trials, COVID-19 research, pandemic, health research clinical trials, coronavirus, COVID-19, SARS-CoV-2, treatment, research, vaccine, study, health, pandemic clinical trials, coronavirus, COVID-19, SARS-CoV-2, clinical research, medical studies, treatment options, vaccine trials, antiviral trials, ongoing studies clinical trials, coronavirus, COVID-19, SARS-CoV-2, medical research, vaccine trials, treatment studies, clinical research, COVID-19 studies, pandemic research clinical trials, coronavirus, COVID-19, SARS-CoV-2, research studies, medical trials, virus, pandemic, treatment options, vaccine trials
18	what are the best masks for preventing infection by Covid-19? masks, Covid-19, face coverings,mask types,respirator, surgical masks, N95, KN95, face mask effectiveness, filtration efficiency, mask comparison, personal protective equipment, PPE, virus prevention, airborne pathogens COVID-19, masks, face coverings, protection, infection prevention, N95, surgical masks, cloth masks, mask efficacy, respiratory protection, virus transmission, PPE, mask fit, filtration, airborne particles masks, COVID-19, coronavirus, mask types, N95, surgical masks, cloth masks, face coverings, filtration efficiency, mask fit, mask materials, respiratory protection, infection prevention, personal protective equipment, PPE, mask efficacy Covid-19, masks, best masks, infection prevention, face masks, N95, surgical masks, protective masks, mask effectiveness, respiratory protection, virus transmission, mask materials, immune protection, mask fitting, mask standards masks, Covid-19, prevention, best, protection, respiratory, N95, surgical, cloth, mask efficacy, filtration, virus, airborne, safety, healthcare, guidelines
19	what type of hand sanitizer is needed to destroy Covid-19? hand sanitizer, type, disinfectant, effectiveness, Covid-19, SARS-CoV-2, alcohol concentration, antiviral, kills, virus, sanitization, gel, liquid, CDC, WHO hand sanitizer, Covid-19, effectiveness, alcohol content, disinfectant, virus, alcohol-based, hand hygiene, sanitizing agents, virus elimination hand sanitizer, type, COVID-19, effectiveness, alcohol content, EPA approval, disinfectant, virus, bacteria, hand hygiene hand sanitizer, Covid-19, disinfectant, alcohol-based, antimicrobial, effectiveness, virucidal, ethanol, isopropanol, sanitization, virus, pandemic, usage, guidelines hand sanitizer, type, effectiveness, Covid-19, coronavirus, alcohol-based, CDC, WHO, ethanol, isopropanol, contact time, alcohol concentration, viral inactivation
1	what is the origin of COVID-19 COVID-19, origin, zoonotic, coronavirus, SARS-CoV-2, Wuhan, outbreak, virus emergence, pandemic, animal source, lab leak, spillover, viral evolution, epidemiology COVID-19, origin, zoonotic transmission, coronavirus, SARS-CoV-2, Wuhan, outbreak, pandemic, virus evolution, animal reservoirs, infectious disease, early cases, viral emergence COVID-19, origin, history, virus, SARS-CoV-2, zoonotic, pandemic, emergence, initial cases, Wuhan, virus jump, animal reservoir, laboratory, spillover COVID-19, origin, virus, SARS-CoV-2, pandemic, zoonotic, spillover, Wuhan, China, coronavirus, outbreak, emergence, source, animal vectors, lab leak, epidemiology COVID-19, origin, source, Wuhan, coronavirus, SARS-CoV-2, emergence, zoonotic, outbreak, pandemic, virus, history, cause, lab, spillover, environmental factors
2	how does the coronavirus respond to changes in the weather coronavirus, COVID-19, weather, climate, transmission, environmental factors, temperature, humidity, viral stability, infection, pandemic, epidemiology coronavirus, COVID-19, weather, climate, temperature, humidity, transmission, infection rate, environmental factors, viral survival, weather patterns, respiratory viruses, seasonal variation coronavirus, COVID-19, weather, climate, temperature, humidity, virus transmission, respiratory viruses, seasonal patterns, epidemiology, weather impact, viral stability, environmental factors coronavirus,weather,climate,virus,transmission,seasonality,temperature,humidity,COVID-19,respiratory,public health,viral behavior coronavirus, COVID-19, weather, climate, temperature, humidity, virus transmission, seasonal variation, respiratory viruses, infectious disease, weather impact, public health
3	will SARS-CoV2 infected people develop immunity? Is cross protection possible? SARS-CoV-2, COVID-19, immunity, immune response, cross-protection, antibodies, memory cells, reinfection, immune memory, vaccine, seroconversion, herd immunity, immune defense, viral shedding, neutralizing antibodies SARS-CoV-2, immunity, immune response, infection, cross-protection, cross-immunity, antibodies, T-cell response, reinfection, vaccines, neutralizing antibodies, immune memory, herd immunity, immune duration SARS-CoV-2, immunity, infection, immune response, cross-protection, antibodies, T-cell immunity, reinfection, herd immunity, immune memory, vaccine, coronavirus, immune system SARS-CoV-2, immunity, cross-protection, reinfection, immune response, antibodies, T-cell response, immune memory, vaccine-induced immunity, natural immunity SARS-CoV-2, COVID-19, immunity, immune response, cross-protection, herd immunity, antibodies, T-cell response, reinfection, immune memory, vaccine-induced immunity, natural immunity, immune duration, serology, immune evasion
4	what causes death from Covid-19? Covid-19, SARS-CoV-2, causes, death, mortality, complications, respiratory failure, cytokine storm, organ failure, comorbidities, risk factors, symptoms, severe illness, pneumonia, ventilator, age, immunity COVID-19, causes, death, mortality, complications, respiratory failure, cytokine storm, comorbidities, risk factors, symptoms, progression, severe cases Covid-19, SARS-CoV-2, causes, mortality, death, risk factors, complications, comorbidities, respiratory failure, pneumonia, cytokine storm, immune response, age, underlying conditions, viral load, severe illness, hospitalization, treatment, vaccines Covid-19, causes, death, mortality, SARS-CoV-2, risk factors, symptoms, comorbidities, complications, respiratory failure, cytokine storm, age, underlying conditions Covid-19, causes, death, mortality, SARS-CoV-2, risk factors, complications, respiratory failure, comorbidities, immune response, cytokine storm, age, underlying health conditions
5	what drugs have been active against SARS-CoV or SARS-CoV-2 in animal studies? drugs, active, SARS-CoV, SARS-CoV-2, animal studies, antiviral, efficacy, preclinical, in vivo, therapeutics, compounds, treatment, experimental, virus, infection drugs, antiviral, SARS-CoV, SARS-CoV-2, animal studies, preclinical, efficacy, treatment, therapeutics, in vivo, research, compounds, virus inhibition, pharmacology drugs, SARS-CoV, SARS-CoV-2, animal studies, antiviral, therapeutics, in vivo, efficacy, treatment, preclinical, pharmacology, viral inhibition drugs, SARS-CoV, SARS-CoV-2, animal studies, antiviral, efficacy, in vivo, preclinical, treatment, therapeutics, research drugs, SARS-CoV, SARS-CoV-2, antiviral, activity, animal studies, efficacy, treatment, preclinical, in vivo, compounds, therapeutic, research
6	what types of rapid testing for Covid-19 have been developed? Covid-19, rapid testing, diagnostic methods, testing techniques, antigen tests, PCR tests, molecular tests, antibody tests, home testing, point-of-care testing, lateral flow assays, clinical validation rapid testing, Covid-19, diagnostic methods, testing types, COVID-19 detection, rapid diagnostic tests, antigen tests, molecular tests, PCR, lateral flow assays, point-of-care testing, at-home testing, COVID-19 screening rapid testing, Covid-19, diagnostics, types, development, detection methods, antigen tests, PCR tests, antibody tests, point-of-care testing, lateral flow assays, molecular testing, testing technology, COVID-19 testing methods Covid-19, rapid testing, diagnostic methods, test types, antigen tests, molecular tests, PCR tests, at-home testing, point-of-care tests, test accuracy, testing technology, developed tests COVID-19, rapid testing, diagnostic methods, testing technologies, antigen tests, PCR tests, molecular diagnostics, point-of-care testing, rapid diagnostic tests, COVID-19 detection
7	are there serological tests that detect antibodies to coronavirus? serological tests, antibodies, coronavirus, COVID-19, detection, serology, antibody testing, immune response, diagnostic tests serological tests, coronavirus, antibodies, detection, COVID-19, antibody tests, serology, virus antibodies, immune response, diagnostic tests serological tests, COVID-19, coronavirus, antibody detection, antibody tests, serology, SARS-CoV-2, immune response, diagnostic tests, antibody testing serological tests, antibodies, coronavirus, COVID-19, antibody detection, serology, diagnostic tests, SARS-CoV-2, antibody assays, antibody testing serological tests, coronavirus, antibodies, detection, serology, antibody tests, COVID-19, diagnostic tests, immune response, seroprevalence
8	how has lack of testing availability led to underreporting of true incidence of Covid-19? Covid-19, testing availability, underreporting, true incidence, disease surveillance, testing capacity, diagnostic testing, case detection, epidemiology, reporting accuracy, public health, testing limitations, case confirmation, data accuracy, pandemic monitoring Covid-19, testing availability, underreporting, true incidence, disease reporting, testing access, diagnostic testing, epidemiology, case detection, surveillance, testing capacity, public health, infection rates, data accuracy, reporting bias Covid-19, testing availability, underreporting, incidence, case detection, testing access, diagnostic testing, disease surveillance, testing capacity, epidemiology, reporting accuracy, public health, testing infrastructure Covid-19, testing availability, underreporting, incidence, case detection, testing capacity, false negatives, diagnostic delays, surveillance, epidemiology, public health, reporting accuracy, testing infrastructure Covid-19, testing availability, underreporting, incidence, disease prevalence, testing capacity, diagnostic testing, case detection, surveillance, public health, epidemiology, testing accessibility, reporting accuracy
9	how has COVID-19 affected Canada COVID-19, Canada, pandemic, healthcare, economy, unemployment, government policies, vaccination, public health, mental health, travel restrictions, border closures, education, remote work, economic impact, social distancing, outbreak management, COVID variants COVID-19, Canada, pandemic, impact, economy, health, government response, public health, lockdowns, vaccination, travel restrictions, employment, mental health, education, healthcare systems COVID-19, pandemic, Canada, health impact, economic effects, government response, vaccination, public health, travel restrictions, unemployment, mental health, healthcare system, economic recovery, Canadian cities, COVID-19 statistics COVID-19, Canada, pandemic, impact, health, economy, government response, public health, vaccination, unemployment, travel restrictions, mental health, economic recovery, policies, cases, mortality rate, healthcare system, economic aid, lockdowns, social distancing COVID-19, Canada, pandemic, health impacts, economic effects, government response, public health, vaccination, travel restrictions, employment, education, mental health, healthcare system, economic recovery, policy changes
20	are patients taking Angiotensin-converting enzyme inhibitors (ACE) at increased risk for COVID-19? Angiotensin-converting enzyme inhibitors, ACE inhibitors, COVID-19, SARS-CoV-2, infection risk, hypertension, cardiovascular drugs, respiratory illness, antiviral response, medication safety, medical research ACE inhibitors, COVID-19, SARS-CoV-2, hypertension, cardiovascular, risk factors, medication, angiotensin receptor blockers, ACE, COVID-19 susceptibility, infection risk, clinical studies, drug safety ACE inhibitors, angiotensin-converting enzyme inhibitors, COVID-19, SARS-CoV-2, infection risk, hypertension, cardiovascular drugs, respiratory illnesses, antiviral, medication safety, clinical outcomes, immune response ACE inhibitors, Angiotensin-converting enzyme inhibitors, COVID-19, SARS-CoV-2, risk factors, hypertension, cardiovascular drugs, antiviral response, ACE2 receptor, comorbidities, infection, medication effects, respiratory viruses ACE inhibitors, Angiotensin-converting enzyme, COVID-19, SARS-CoV-2, patient risk, hypertension, cardiovascular medications, viral infection, clinical outcomes, epidemiology, observational studies, medication safety
21	what are the mortality rates overall and in specific populations mortality rates, overall, specific populations, death rates, demographic groups, mortality statistics, public health, epidemiology, health outcomes, mortality data mortality, death rates, overall mortality, population-specific mortality, demographic differences, disease-specific mortality, age groups, gender, health disparities, epidemiology mortality, death rates, overall mortality, population-specific mortality, demographic factors, age groups, health conditions, mortality statistics, epidemiology, public health mortality rates, overall, specific populations, death rates, demographic groups, age groups, gender differences, health conditions, geographic locations, temporal trends, cause-specific mortality, epidemiology, public health mortality rates, overall, specific populations, death statistics, mortality statistics, demographic groups, age groups, healthcare, epidemiology, mortality factors, population health
22	are cardiac complications likely in patients with COVID-19? COVID-19, cardiac complications, cardiovascular, myocarditis, arrhythmia, heart failure, prevalence, risk factors, epidemiology, clinical outcomes, incidence, severity, biomarkers, troponin, echocardiogram, myocarditis, myocardial injury, long-term effects, patients COVID-19, cardiac complications, myocarditis, arrhythmia, heart failure, cardiovascular risk, SARS-CoV-2, myocarditis prevalence, cardiac injury, COVID-19 outcomes, long-term cardiac effects COVID-19, cardiac complications, myocarditis, arrhythmia, heart failure, cardiovascular risk, SARS-CoV-2, thromboembolism, chest pain, myocarditis incidence, COVID-19 severity, cardiac biomarkers, echocardiography, myocardial injury, electrocardiogram, age, comorbidities, prognosis COVID-19, cardiac complications, cardiovascular risks, myocarditis, arrhythmias, heart failure, SARS-CoV-2, prevalence, risk factors, clinical outcomes, myocardial injury, biomarkers, epidemiology, respiratory infection, immune response COVID-19, cardiac complications, cardiovascular, myocarditis, arrhythmia, heart failure, clinical outcomes, prevalence, risk factors, diagnosis, treatment, prognosis
23	what kinds of complications related to COVID-19 are associated with hypertension? COVID-19, complications, hypertension, cardiovascular, respiratory, co-morbidities, risk factors, effects, severity, mortality, immune response, cytokine storm, organ failure, hypertension management, COVID-19 outcomes COVID-19, complications, hypertension, comorbidities, risk factors, cardiovascular, respiratory, immune response, mortality, severity, elderly, ACE2 receptors, inflammation, thrombosis COVID-19, hypertension, complications, comorbidities, cardiovascular, respiratory, viral infection, risk factors, severity, mortality, immune response, hypertensive crises COVID-19, hypertension, complications, comorbidities, cardiovascular, respiratory, immune response, severity, risk factors, mortality, viral infection, blood pressure, cytokine storm, organ failure COVID-19, hypertension, complications, cardiovascular, respiratory, thrombotic, mortality, risk factors, immune response, ACE2 receptor, comorbidities
24	what kinds of complications related to COVID-19 are associated with diabetes COVID-19, diabetes, complications, hyperglycemia, immune response, respiratory issues, cardiovascular, kidney injury, neuropathy, mortality, risk factors, inflammation, cytokine storm, insulin resistance, comorbidities COVID-19, complications, diabetes, diabetic patients, comorbidities, hyperglycemia, immune response, respiratory failure, cardiovascular issues, inflammation, cytokine storm, hospitalization, mortality, risk factors, management COVID-19, diabetes, complications, associations, hyperglycemia, respiratory issues, thromboembolism, immune response, hospitalization, mortality, cytokine storm, insulin resistance, organ failure, risk factors, comorbidities COVID-19, diabetes, complications, comorbidities, hyperglycemia, immune response, respiratory failure, thromboembolism, inflammation, hospitalization, mortality, risk factors, glycemic control, diabetic ketoacidosis, cytokine storm, infection severity, SARS-CoV-2, metabolic effects, immunocompromised COVID-19, diabetes, complications, comorbidities, respiratory issues, cardiovascular, immune response, hyperglycemia, mortality, risk factors, severity, hospitalization, long COVID, inflammation, hypertension
25	which biomarkers predict the severe clinical course of 2019-nCOV infection? biomarkers, predictive, severity, clinical course, 2019-nCoV, COVID-19, prognosis, inflammatory markers, cytokines, laboratory indicators biomarkers, predictive, severity, clinical course, 2019-nCoV, COVID-19, prognosis, inflammatory markers, cytokines, biomarkers validity, disease progression biomarkers, predictors, severe, clinical, course, 2019-nCoV, COVID-19, prognosis, severity markers, laboratory findings, inflammatory markers, cytokines, immune response, viral load, patient outcomes biomarkers, predictors, severe, clinical course, 2019-nCOV, COVID-19, prognostic indicators, disease severity, inflammation markers, cytokines, laboratory tests, risk factors biomarkers, predictors, severe, clinical course, 2019-nCOV, COVID-19, prognosis, severity markers, laboratory findings, inflammatory markers, cytokines, biochemical indicators, clinical predictors
26	what are the initial symptoms of Covid-19? Covid-19,initial symptoms,early signs,SARS-CoV-2,respiratory symptoms,fever,cough,tiredness,loss of taste,loss of smell,shortness of breath,fatigue,headache,sore throat Covid-19, initial symptoms, early signs, coronavirus, COVID, fever, cough, fatigue, shortness of breath, sore throat, loss of taste, loss of smell, incubation period, symptoms timeline Covid-19, initial symptoms, early signs, symptoms, disease, respiratory symptoms, fever, cough, fatigue, sore throat, loss of taste, loss of smell, shortness of breath, incubation, transmission, virus, COVID, signs, onset Covid-19, initial symptoms, early signs, fever, cough, fatigue, shortness of breath, sore throat, body aches, loss of taste, loss of smell, incubation period, contagious, virus symptoms Covid-19, initial symptoms, early signs, COVID-19 symptoms, symptom onset, coronavirus symptoms, fever, cough, fatigue, shortness of breath, loss of taste, loss of smell, sore throat, headaches, muscle aches
27	what is known about those infected with Covid-19 but are asymptomatic? Covid-19, asymptomatic, infection, transmission, symptomless, viral load, prevalence, epidemiology, immune response, testing, silent carriers, public health, contagiousness, disease progression Covid-19, asymptomatic, infection, silent carriers, viral load, transmission, immunity, epidemiology, symptomless, prevalence, incubation, public health Covid-19, asymptomatic, infection, viral load, transmission, immune response, epidemiology, symptoms, disease progression, testing, screening, prevalence, clinical features, public health Covid-19, asymptomatic, infection, transmission, prevalence, immune response, viral load, epidemiology, silent spread, symptomless carriers Covid-19, SARS-CoV-2, asymptomatic, infection, prevalence, viral load, transmission, silent carriers, epidemiology, symptoms, immune response, testing, RT-PCR, serology, public health
28	what evidence is there for the value of hydroxychloroquine in treating Covid-19? hydroxychloroquine, Covid-19, evidence, efficacy, clinical trials, research, studies, treatment, antiviral, success rates, safety, effectiveness, mechanisms, outcomes, published data hydroxychloroquine, Covid-19, evidence, clinical trials, efficacy, treatment, COVID-19, research, studies, outcomes, antiviral, immune response, scientific evidence, safety, effectiveness hydroxychloroquine, COVID-19, antiviral, clinical trials, efficacy, treatment, medical research, randomized controlled trial, evidence, case studies, published studies, scientific reviews, safety, side effects, drug effectiveness, therapeutic outcomes hydroxychloroquine, Covid-19, evidence, clinical trials, efficacy, effectiveness, treatment, antiviral, research, studies, outcomes, side effects, safety, meta-analysis, randomized controlled trial hydroxychloroquine, COVID-19, evidence, clinical trials, efficacy, treatment, antiviral, randomized studies, research, outcomes, safety, side effects, medical evidence
29	which SARS-CoV-2 proteins-human proteins interactions indicate potential for drug targets. Are there approved drugs that can be repurposed based on this information? SARS-CoV-2, human proteins, protein interactions, drug targets, antiviral drugs, drug repurposing, approved medications, COVID-19 therapeutics, protein-protein interaction analysis, therapeutic targets, drug discovery, viral-host interaction, COVID-19 treatment, drug database, molecular docking SARS-CoV-2, viral proteins, human proteins, protein interactions, drug targets, drug repurposing, approved drugs, COVID-19, proteomics, molecular docking, therapeutic targets, antiviral agents, host-pathogen interactions, drug discovery SARS-CoV-2, coronavirus, viral proteins, human proteins, protein-protein interactions, drug targets, drug repurposing, approved drugs, COVID-19 therapeutics, antiviral drugs, proteomics, interactome analysis, host-virus interactions, drug discovery, pharmacology, bioinformatics, repurposing strategies SARS-CoV-2, human proteins, protein interactions, drug targets, drug repurposing, approved drugs, COVID-19, antiviral drugs, protein-protein interactions, therapeutic targets, drug discovery SARS-CoV-2, viral proteins, human proteins, protein-protein interactions, drug targets, drug repurposing, approved drugs, COVID-19, therapeutics, pharmacology, antiviral agents, molecular docking, bioinformatics, host-pathogen interactions, drug discovery
30	is remdesivir an effective treatment for COVID-19 remdesivir, COVID-19, antiviral, treatment, efficacy, clinical trials, COVID-19 therapy, SARS-CoV-2, drug effectiveness, medical research remdesivir, COVID-19, antiviral, treatment, efficacy, clinical trials, COVID-19 therapy, antiviral drugs, SARS-CoV-2, evidence, effectiveness remdesivir, effectiveness, COVID-19, treatment, antiviral, clinical trials, efficacy, health outcomes, research, COVID-19 therapy remdesivir, COVID-19, antiviral, treatment, effectiveness, clinical trials, efficacy, SARS-CoV-2, hospitalization, recovery, therapy remdesivir, COVID-19, antiviral, treatment, efficacy, clinical trials, SARS-CoV-2, drug effectiveness, antiviral therapy, COVID-19 treatment
31	How does the coronavirus differ from seasonal flu? coronavirus, seasonal flu, differences, comparison, symptoms, transmission, severity, viruses, COVID-19, influenza, contagiousness, vaccine, impacts, mortality coronavirus, COVID-19, seasonal flu, influenza, differences, symptoms, transmission, severity, mortality, vaccines, variants, contagiousness, incubation period, prevention coronavirus, COVID-19, seasonal flu, influenza, differences, symptoms, transmission, severity, vaccines, mortality rate, incubation period, contagiousness, virus structure, immune response, public health coronavirus, COVID-19, seasonal flu, influenza, differences, symptoms, transmission, vaccine, severity, immune response, incubation period, mortality rate coronavirus, COVID-19, seasonal flu, influenza, differences, symptoms, transmission, severity, incubation period, immunity, vaccines, prevention, treatment
32	Does SARS-CoV-2 have any subtypes, and if so what are they? SARS-CoV-2, subtypes, variants, strains, lineages, mutation, genomic diversity, coronavirus, COVID-19, viral evolution SARS-CoV-2, subtypes, variants, strains, mutations, lineages, classification, genetic diversity, virus evolution SARS-CoV-2,subtypes,variants,genetic variations,viral strains,mutations,lineages,clades,coronavirus classification,viral evolution,variant nomenclature SARS-CoV-2,subtypes,variants,genetic lineages,viral mutations,Omicron,Delta,classification,bioinformatics,viral evolution,strain diversity,clade,phylogenetics,RNA virus,coronavirus,mutation sites SARS-CoV-2,variants,subtypes,strains,mutations,lineages,coronavirus,genetic diversity,viral evolution,viral classifications
33	What vaccine candidates are being tested for Covid-19? Covid-19, vaccine candidates, clinical trials, vaccine development, COVID-19 vaccines, vaccine research, SARS-CoV-2, vaccine testing, immunization, vaccine efficacy Covid-19, vaccine candidates, clinical trials, vaccine development, COVID vaccines, vaccine research, vaccine candidates testing, vaccine efficacy, mRNA vaccines, viral vector vaccines, vaccine pipeline, ongoing trials, vaccine approvals, immunization trials Covid-19, vaccine candidates, clinical trials, vaccine development, Covid-19 vaccines, vaccine research, SARS-CoV-2, vaccine candidates testing, vaccine efficacy, vaccine authorization COVID-19, vaccine candidates, clinical trials, vaccine development, SARS-CoV-2, vaccine research, Phase I trials, Phase II trials, Phase III trials, vaccine efficacy, vaccine candidates list, mRNA vaccines, vector vaccines, protein subunit vaccines, vaccine platforms, emerging vaccines Covid-19, vaccine candidates, clinical trials, vaccine research, vaccine development, COVID vaccines, vaccine testing, vaccine efficacy, vaccine platforms, phase I trials, phase II trials, phase III trials, vaccine candidates list
34	What are the longer-term complications of those who recover from COVID-19? COVID-19, long-term complications, post-viral syndrome, long COVID, sequelae, persistent symptoms, health effects, post-COVID condition, chronic issues, recovery, epidemiology COVID-19, long-term complications, recovery, Post-Acute Sequelae, Long COVID, symptoms, persistent effects, rehabilitation, respiratory issues, cardiovascular effects, neurological symptoms, fatigue, mental health, chronic conditions, pulmonary complications, rehabilitation, immune response, biomarkers COVID-19, long-term complications, post-viral syndrome, long COVID, recovery, persistent symptoms, chronic effects, post-acute sequelae, PASC, respiratory issues, cardiovascular effects, neurological symptoms, fatigue, dyspnea, mental health, lung fibrosis, organ damage, rehabilitation, immune response, epidemiology COVID-19,long-term complications,recovery,post-acute sequelae,long COVID,multisystem effects,persistent symptoms,post-COVID syndrome,chronic symptoms,long-term effects,health consequences,post-infection effects,rehabilitation,convalescence,post-viral syndrome COVID-19, long-term complications, long COVID, post-acute sequelae, long-haul COVID, symptoms, recovery, respiratory issues, cardiovascular effects, neurological effects, fatigue, cognitive impairment, mental health, organ damage, rehabilitation, persistent symptoms
35	What new public datasets are available related to COVID-19? COVID-19, public datasets, open data, pandemic data, health datasets, epidemiology, virus data, COVID-19 statistics, public health data, datasets repository, COVID-19 research, pandemic datasets COVID-19, public datasets, COVID-19 datasets, open data, pandemic data, health data, epidemiology datasets, coronavirus data, COVID-19 statistics, disease surveillance, public health data COVID-19, public datasets, datasets, data repositories, open data, pandemic data, COVID-19 data, data sources, health data, epidemiological data COVID-19, public datasets, COVID-19 data, pandemic datasets, SARS-CoV-2, open data, health datasets, epidemiology data, virus transmission, COVID-19 statistics, outbreak data, COVID-19 research data COVID-19, public datasets, new datasets, pandemic data, epidemiology, virus tracking, health data, open data, COVID-19 repositories, dataset updates
36	What is the protein structure of the SARS-CoV-2 spike? protein, structure, SARS-CoV-2, spike, viral, glycoprotein, 3D-model, receptor-binding domain, ACE2, crystallography, cryo-EM, mutation, antigenic sites, conformational changes protein structure, SARS-CoV-2, spike, spike protein, virus, coronavirus, glycoprotein, receptor-binding domain, RBD, 3D structure, cryo-electron microscopy, crystallography, ACE2 interaction, mutational analysis SARS-CoV-2, spike protein, structure, 3D model, amino acid sequence, receptor-binding domain, antibody binding, crystallography, cryo-electron microscopy, glycosylation, spike conformations, viral entry SARS-CoV-2, spike protein, viral glycoprotein, protein structure, 3D structure, receptor-binding domain, RBD, cryo-electron microscopy, X-ray crystallography, ACE2 binding, conformational changes, protein modeling, structural analysis SARS-CoV-2, Spike protein, Protein structure, Coronavirus, Viral glycoprotein, Receptor-binding domain, ACE2 interaction, Cryo-electron microscopy, 3D modeling, Molecular dynamics, Antigenic sites, Fusion peptide, N-terminal domain, C-terminal domain, Structural analysis
37	What is the result of phylogenetic analysis of SARS-CoV-2 genome sequence? phylogenetic analysis, SARS-CoV-2, genome sequence, viral evolution, phylogenetics, COVID-19, genome sequencing, virus phylogeny, mutation analysis, phylogenetic tree, genetic diversity, viral genealogy phylogenetic analysis, SARS-CoV-2, genome sequence, evolutionary relationships, phylogeny, viral evolution, genetic diversity, sequence alignment, phylogenetic tree, molecular phylogenetics, coronavirus, genomic data, mutation analysis, lineage classification phylogenetic analysis, SARS-CoV-2, genome sequencing, viral evolution, phylogeny, genetic diversity, mutation patterns, virus genealogy, sequence alignment, evolutionary relationships phylogenetic analysis, SARS-CoV-2, genome sequence, viral evolution, phylogenetics, sequence alignment, genetic diversity, viral phylogeny, mutation patterns, lineage tracing phylogenetic analysis, SARS-CoV-2 genome, sequence analysis, viral evolution, phylogenetics, genome sequencing, phylogenetic tree, genetic diversity, virus mutation, bioinformatics, viral genomics
38	What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases? inflammatory response, pathogenesis, COVID-19, SARS-CoV-2, immune response, cytokine storm, viral replication, lung injury,ACE2 receptor, immune system, cytokines, inflammation, respiratory failure, viral entry, immune modulation inflammatory response, pathogenesis, COVID-19, SARS-CoV-2, immune system, cytokine storm, viral infection, innate immunity, adaptive immunity, lung inflammation, cytokines, immune response, viral replication, ACE2 receptor, tissue damage, immune modulation inflammatory response, pathogenesis, COVID-19, SARS-CoV-2, immune system, cytokine storm, viral infection, lung inflammation, immune response, symptoms, immune pathways, cytokines, immune cells, alveolar damage, viral entry, alveolar macrophages, ACE2 receptor, viral replication, immune evasion, acute respiratory distress syndrome, immune regulation inflammatory response, pathogenesis, COVID-19, immune system, cytokine storm, SARS-CoV-2, virus entry, immune activation, lung inflammation, cytokines, immune dysregulation, viral replication, alveolar damage, ACE2 receptor, molecular mechanisms inflammatory response, pathogenesis, COVID-19, mechanism, immune response, cytokine storm, SARS-CoV-2, viral infection, immune system, inflammation, alveolar damage, lung injury, adaptive immunity, innate immunity, ACE2 receptor, viral replication, cytokines, immune modulation
39	What is the mechanism of cytokine storm syndrome on the COVID-19? cytokine storm, COVID-19, mechanism, cytokines, immune response, hyperinflammation, cytokine release syndrome, SARS-CoV-2, immune system, inflammatory pathways, interleukins, tumor necrosis factor, immune dysregulation cytokine storm, cytokine storm syndrome, COVID-19, SARS-CoV-2, immune response, hyperinflammation, cytokines, interleukins, tumor necrosis factor, IL-6, immune system dysregulation, cytokine cascade, hypercytokinemia, inflammation, respiratory distress, cytokine profiles cytokine storm, immune response, COVID-19, SARS-CoV-2, hyperinflammation, cytokines, interleukins, interferons, immune dysregulation, severe COVID-19, inflammation pathway, cytokine release syndrome cytokine storm, syndrome, COVID-19, mechanism, hyperinflammation, cytokines, immune response, cytokine cascade, severe illness, immunopathology cytokine storm, syndrome, COVID-19, mechanism, immune response, cytokines, inflammation, hyperinflammation, cytokine cascade, immune dysregulation, cytokine release syndrome, SARS-CoV-2, immunopathology
40	What are the observed mutations in the SARS-CoV-2 genome and how often do the mutations occur? SARS-CoV-2, mutations, genome, mutation frequency, viral mutations, genetic variations, mutation rates, viral evolution, sequence analysis, mutation hotspots SARS-CoV-2, mutations, genome, observed mutations, mutation frequency, viral evolution, genetic variation, mutation rate, variants, sequencing data, mutation analysis SARS-CoV-2, mutations, genome, genetic variations, mutation rate, viral evolution, spike protein, variants, nucleotide changes, mutation frequency, genomic sequencing, mutation hotspots, viral mutations, mutation patterns, epidemiology, mutation prevalence SARS-CoV-2, mutations, genome, genetic variations, mutation frequency, viral evolution, variant analysis, mutation hotspots, sequencing, genomic surveillance, viral mutations, mutation rate, mutation types, mutation distribution, genomic diversity SARS-CoV-2, mutations, genome, genetic variations, mutation frequency, viral mutations, mutation rates, mutation hotspots, genomic alterations, mutation analysis, viral evolution, nucleotide changes, variant sequencing
41	What are the impacts of COVID-19 among African-Americans that differ from the rest of the U.S. population? COVID-19, African-Americans, health disparities, racial disparities, racial impact, COVID-19 outcomes, pandemic effects, social determinants, healthcare access, mortality rates, infection rates, socioeconomic factors, healthcare disparities, minority health, racial inequality COVID-19, African-Americans, racial disparities, health outcomes, socioeconomic factors, healthcare access, mortality rates, infection rates, comorbidities, vaccine coverage, social determinants, healthcare disparities, immigrant status, community impact, economic effects COVID-19, African-Americans, racial disparities, health outcomes, socioeconomic factors, healthcare access, mortality rates, infection rates, pre-existing conditions, social determinants of health, healthcare disparities, racial inequities, COVID-19 impact, minority health, public health, racial disparities in healthcare COVID-19, African-Americans, racial disparities, health disparities, pandemic impact, mortality rates, healthcare access, socioeconomic factors, comorbidities, racial inequities, public health, infection rates, vaccination rates, social determinants of health, economic impact, community health COVID-19, African-Americans, health disparities, racial health inequities, COVID-19 impact, minority health, racial disparities, socio-economic factors, healthcare access, pandemic effects, racial health outcomes, public health, COVID-19 morbidity, COVID-19 mortality, social determinants of health, health equity
42	Does Vitamin D impact COVID-19 prevention and treatment? Vitamin D, COVID-19, SARS-CoV-2, immunity, prevention, treatment, supplementation, deficiency, clinical trials, research, antiviral, immune response, cytokine, respiratory infections, supplementation efficacy Vitamin D, COVID-19, prevention, treatment, impact, efficacy, supplementation, immune response, immune system, respiratory infections, antiviral, antiviral effect, deficiency, clinical trials, randomized studies, respiratory health Vitamin D, COVID-19, prevention, treatment, immune response, supplementation, antiviral, respiratory infections, cytokine response, clinical trials, deficiency, immunity, SARS-CoV-2 Vitamin D, COVID-19, SARS-CoV-2, prevention, treatment, immune response, supplementation, deficiency, clinical trials, cytokine storm, antiviral, respiratory infections Vitamin D, COVID-19, prevention, treatment, supplementation, immunity, immune response, infection risk, antiviral, inflammation, respiratory health, clinical trials, immune modulation, deficiency, antiviral effects
43	How has the COVID-19 pandemic impacted violence in society, including violent crimes? COVID-19, pandemic, violence, societal impact, violent crimes, crime rates, mental health, lockdowns, social behavior, law enforcement, public safety, domestic violence, crime statistics, social distancing, economic impact, community safety, crime prevention, health crises, police response COVID-19, pandemic, violence, society, violent crimes, impact, crime rates, public health, social behavior, lockdown, mental health, domestic violence, crime statistics, emergency services, socioeconomic factors COVID-19, pandemic, violence, societal impact, violent crimes, crime rates, public safety, lockdown, mental health, economic hardship, domestic violence, social behavior, law enforcement, crime statistics, societal changes COVID-19, pandemic, violence, society, violent crimes, impact, crime rates, social behavior, public health, crime statistics, lockdown, mental health, domestic violence, community safety, law enforcement, behavioral changes COVID-19, pandemic, violence, societal impact, criminal activities, crime rates, public health, social behavior, lockdown, mental health, domestic violence, crime statistics, social disruption, public safety, law enforcement